BLOOMFIELD, Conn., July 9, 2024 /PRNewswire/ -- Global health company The Cigna Group (NYSE: CI) released its 2023 environmental, social, and governance (ESG) report, detailing the organization's ongoing efforts to strengthen communities and drive improvement to a more sustainable and equitable health care system.
"The Cigna Group is a purpose-built, high-performance organization dedicated to creating positive change around the world," said Geneva Brown, vice president, ESG and diversity, equity and inclusion, The Cigna Group. "We are committed to advancing our efforts to realize the vision we have for a better future built on the vitality of every individual and every community."
The Cigna Group's multi-dimensional ESG framework is based on four key pillars: Healthy Society, Healthy Workforce, Healthy Environment, and Healthy Company. The report includes key performance indicators, reporting, and recognitions. Learn more about the company's ESG efforts here.
About The Cigna Group
The Cigna Group (NYSE:CI) is a global health company committed to creating a better future built on the vitality of every individual and every community. We relentlessly challenge ourselves to partner and innovate solutions for better health. The Cigna Group includes products and services marketed under Cigna Healthcare, Evernorth Health Services, or its subsidiaries. The Cigna Group maintains sales capabilities in more than 30 countries and jurisdictions and has more than 187 million customer relationships around the world. Learn more at thecignagroup.com.
Media Contact
Madeline Ziomek
(202) 615-1473
This email address is being protected from spambots. You need JavaScript enabled to view it.

| Last Trade: | US$274.70 |
| Daily Change: | 2.44 0.90 |
| Daily Volume: | 1,716,450 |
| Market Cap: | US$73.380B |
October 30, 2025 June 12, 2025 | |

ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...
CLICK TO LEARN MORE
Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...
CLICK TO LEARN MOREEnd of content
No more pages to load